FDA approved Eli Lilly and Company's Alzheimer's drug Kinsula for commercialization in the U.S. market.

Amgen Biotech has adopted a series of new strategies for the weight loss drugs market to compete with industry giants such as Novo Nordisk and Eli Lilly.

According to the Hong Kong Stock Exchange recently disclosed documents, Sichuan Colun Botai Biopharmaceutical Co., Ltd. issued an announcement (hereinafter referred to as Colun Botai) that the company will be in June 29, 2023 to July 4, the joint sponsors are Goldman Sachs and CITIC Securities.。

On May 31, Cody Group (listing name: Cody-B) announced its prospectus on the HKEx.。According to the announcement, the company will open the public offering in Hong Kong at 9: 00 a.m. on May 31, 2023 (Wednesday) and close the subscription on June 5, 2023 (Monday)。